| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Departments of Anaesthesia and Intensive Care, Cairns Base Hospital, Cairns, Australia; and
The Leopold-Franzens University, Innsbruck, Austria.
Address correspondence to: Prof. J. Brimacombe, Department of Anaesthesia and Intensive Care, Cairns Base Hospital, The Esplanade, Cairns 4870, Australia. E-mail: jbrimaco{at}bigpond.net.au
| Abstract |
|---|
|
|
|---|
Methods: Twenty previously used ClassicTM and FlexibleTM LMAs were hand washed, machine washed, dried, autoclaved and then randomly allocated into four groups for supplementary cleaning. In Group A, the dorsal surface was immersed in water and the surface scrubbed with a high-speed rotating brush. In Group B, the dorsal surface was immersed in a plaque removing solution. In Group C, the dorsal surface was immersed in a protein removing solution. In Group D (controls), the dorsal surface was immersed in water. Before and after supplementary cleaning the LMAs were immersed in a protein staining solution, rinsed and a high-resolution digital image taken of the dorsal surface. The location and severity of staining were scored by two observers blinded to group assignment.
Results: Staining was similar before and after supplementary cleaning for all groups. Mild, moderate and severe staining occurred in 31%, 7% and 2% of zones respectively; 60% were unstained. Staining was less common on the cuff than on the backplate and distal tube (both: P < 0.00001). Staining was less common on the backplate than on the distal tube (P = 0.001). Staining was always present on the mid-portion of the backplate or distal tube.
Conclusion: Supplementary cleaning using a rotating brush, plaque or protein removing solution does not facilitate removal of protein deposits from re-usable LMAs; however, the infectious risk associated with the protein deposits remains to be determined.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
The LMAs were randomly allocated (by opening an opaque envelope) into four equal-sized groups for supplementary cleaning. In Group A, the dorsal surface was immersed in water and the surface scrubbed with a high-speed, 1-cm wide rotating brush for two minutes (3D pulsating toothbrush 4729, Braun, Germany). In Group B, the dorsal surface was immersed in a plaque removing solution for 30 min (Plax Fresh Mouthwash, Colgate Oral Care, Sydney, Australia). In Group C, the dorsal surface was immersed in a protein removing solution for five hours (subtilisin 0.01 mgmL-1 AMO Complete Protein Remover, Advanced Medical Optics, Sydney, Australia). In Group D (controls), the dorsal surface was immersed in water for five hours. Before and after supplementary cleaning the LMAs were immersed for 30 min in a protein staining solution (1.2% erythrosin B),7 rinsed in water at 20°C for one minute and a high resolution digital image (3.3 megapixels) taken of the dorsal surface. The images were analyzed by dividing the dorsal surface into 20 zones (Figure 1
) and scoring the severity of staining in each zone according to the percentage of area stained: 0 (nil), 1 (mild,
10%), 2 (moderate, > 10%50%) and 3 (severe, > 50%). The overall staining score was determined by adding the staining scores from the 20 zones (maximum score 60). The images were analyzed by two observers blinded to the timing of the staining and the type of supplementary cleaning, and the average taken. Another three previously used LMAs (history as above) were collected, stained, cleaned with the protein removing solution, restained and photographed as above, but were also photographed just before the second staining. Sample size was selected for a type I error of 0.05 and a power of 0.85 with four groups and was based on a pilot study with four LMAs with an effect size of 0.644. Statistical analysis was with Chi squared test.
|
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
We found that protein staining was more common on the backplate and distal tube than the cuff. This may be related to their surfaces being more irregular at a microscopic level or due to increased exposure to protein contamination. Interestingly, we found that staining occurred most commonly on the mid-portion of the backplate and distal tube. This is the surface that is pressed most firmly into the mucosa during insertion. We speculate that transient high mucosal pressures combined with shearing forces during insertion increase the level of protein contamination in this area. The presence of severe staining on three linear abrasions indicates the ease with which protein can collect on irregular surfaces.
We found protein deposits on all LMAs before supplementary cleaning confirming Miller et al.s 4 finding that conventional cleaning and autoclaving does not remove all protein deposits; however, our level of contamination may have been lower since moderate and severe staining occurred in less than 10% of zones, whereas Miller et al.4 graded 45% of LMAs as moderately or heavily stained. Our finding that supplementary cleaning removed most of the first stain, but not the underlying protein, as indicated by its reappearance with the second stain, suggests that the first stain did not protect the protein from removal.
The risk of prion disease transmission from re-usable LMAs is unknown. Although the frequency of prion disease is around one per million3 and the number of LMA uses is around 20 million per annum, an accurate estimate of risk cannot be determined since there are no data about the frequency of LMA contamination from an infected patient, no data about the infective dose, and no data about the amount of contaminant removed or denatured with each use/cleaning/autoclave cycle. There are no reports of prion or other infections from re-usable LMAs, but prion transmission via blood8 and oral inoculation9 has been reported in animal models.
We conclude that the supplementary cleaning using a rotating brush, plaque or protein removing solution does not facilitate removal of protein deposits from re-usable LMAs. The mid-portion of the backplate and distal tube is the most heavily stained area on the dorsal surface of the cuff. The infectious risk associated with such protein deposits remains to be determined.
| Footnotes |
|---|
Accepted for publication July 8, 2003. Revision accepted November 28, 2003.
| References |
|---|
|
|
|---|
2 Haltia M. Human prion diseases. Ann Med 2000; 32: 493500.[Medline]
3 Hilton DA. VCJDpredicting the future? Neuropathol Appl Neurobiol 2000; 26: 4057.[Medline]
4 Miller DM, Youkhana I, Karunaratne WU, Pearce A. Presence of protein deposits on cleaned re-usable anaesthetic equipment. Anaesthesia 2001; 56: 106972.[Medline]
5 Smith G. Variant CJD; what you need to know at present. The Royal College of Anaesthetists Bulletin 2001; 7: 3024.
6 Verghese C. LMA-ClassicTM, LMA-FlexibleTM, LMA-UniqueTM. Instruction Manual. Henley-on-Thames: The Laryngeal Mask Company Ltd; 1999.
7 Leknes KN, Lie T. Erythrosin staining in clinical disclosure of plaque. Quintessence Int 1988; 19: 199204.[Medline]
8 Hunter N, Foster J, Chong M, et al. Transmission of prion disease by blood transfusion. J Gen Virol 2002; 83: 2897905.
9 Bartz JC, Kincaid AE, Bessen RA. Rapid prion neuroinvasion following tongue infection. J Virol 2003; 77: 58391.
This article has been cited by other articles:
![]() |
M. Lange, T. Smul, P. Zimmermann, R. Kohlenberger, N. Roewer, and F. Kehl The Effectiveness and Patient Comfort of the Novel Streamlined Pharynx Airway Liner (SLIPA(R)) Compared with the Conventional Laryngeal Mask Airway in Ophthalmic Surgery Anesth. Analg., February 1, 2007; 104(2): 431 - 434. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |